Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

For better result, minimum character length is four(4)
Results 121 - 130 of 200 for wx. (0.06 seconds)

WuXi PharmaTech received ISO 14001 certification for its...
Chongqing Zhifei Biological Products will IPO on...
WuXi PharmaTech announced its new Suzhou toxicology...
Eddingpharm Inc. closed a $24 million Series B financing...
Pfizer announced that its new R&D center in Wuhan is up...
WuXi PharmaTech reported impressive Q3 results, showing...
“In 2010, venture capital investment in China life...
Charles River Labs intends to sell its Shanghai...
Bristol-Myers Squibb announced a strategic partnership...
Shanghai Pharma scheduled its upcoming $1.2 billion Hong...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here